APOC3 Intron 1 Promoter for Transgene Expression

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current promoters are not suitable for various technologies and situations where a specific promoter is required, particularly for the APOC3 gene, which limits the efficient expression of transgenes.

Innovation Solution

A novel promoter derived from part or all of intron 1 of the APOC3 gene, which can be used in nucleic acid constructs to express transgenes, regardless of whether the transgene is integrated into the genome.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If conventional promoters are used, then the promoter structure is well-known and easy to obtain, but the promoter cannot efficiently drive transgene expression in various technologies and situations

Engineering Contradiction:
Improvetransgene expression efficiencyVSAvoidpromoter applicability to various technologies and situations
Core Design Contradiction:
ProductivityVSAdaptability or versatility

Solution Approach 1:

The invention segments the promoter into specific functional regions including a TATA box (SEQ ID NO: 01), a CCAAT box (SEQ ID NO: 02), and a GC box (SEQ ID NO: 03), each contributing specific regulatory functions. This segmentation allows the promoter to be optimized for different expression patterns while maintaining core functionality across various technologies.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The promoter sequence is designed to perform multiple functions simultaneously: it can drive expression in different cell types, work with various transgenes, and be applicable to different delivery methods (viral and non-viral vectors). The combination of conserved elements (TATA box, CCAAT box, GC box) provides universal applicability while maintaining technology-specific adaptability.

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Reliability

If the promoter is designed to be highly specific for certain cell types, then cell-type specific expression is improved, but the promoter loses versatility across different technologies and situations

Engineering Contradiction:
Improvecell-type specific expression controlVSAvoidpromoter applicability
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The promoter incorporates local quality variations through its sequence structure: the TATA box provides strong transcriptional initiation, the CCAAT box adds tissue-specific regulation, and the GC box contributes to stability. This local differentiation of functional elements allows the promoter to achieve cell-type specificity when needed while maintaining overall versatility through the conservation of core elements.

Inventive Principle:
Principle #3Local quality

Data Source

PatentUS20250051749A1Novel promoter and use thereof
Publication Date: 2025.02.13 TOOLGEN INC
  • US20250051749A1 patent drawing
  • US20250051749A1 patent drawing
  • US20250051749A1 patent drawing

AI summary

The present application relates to a novel promoter and a use thereof. In one embodiment of the present application, provided is a nucleic acid construct comprising a novel promoter and a transgene of the present application. At this time, on the nucleic acid construct, the novel promoter of the present application can be operably linked to the transgene.